NASDAQ
MASI

Masimo Corporation

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Masimo Corporation Stock Price

Vitals

Today's Low:
$98.04
Today's High:
$104.77
Open Price:
$104.62
52W Low:
$98.04
52W High:
$198
Prev. Close:
$105.1
Volume:
1553450

Company Statistics

Market Cap.:
$5.55 billion
Book Value:
24.77
Revenue TTM:
$2.19 billion
Operating Margin TTM:
8.78%
Gross Profit TTM:
$1.06 billion
Profit Margin:
5.3%
Return on Assets TTM:
4.02%
Return on Equity TTM:
9.22%

Company Profile

Masimo Corporation had its IPO on 2007-08-08 under the ticker symbol MASI.

The company operates in the Healthcare sector and Medical Devices industry. Masimo Corporation has a staff strength of 4,000 employees.

Stock update

Shares of Masimo Corporation opened at $104.62 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $98.04 - $104.77, and closed at $98.47.

This is a -6.31% slip from the previous day's closing price.

A total volume of 1,553,450 shares were traded at the close of the day’s session.

In the last one week, shares of Masimo Corporation have slipped by -13.31%.

Masimo Corporation's Key Ratios

Masimo Corporation has a market cap of $5.55 billion, indicating a price to book ratio of 6.0848 and a price to sales ratio of 4.3437.

In the last 12-months Masimo Corporation’s revenue was $2.19 billion with a gross profit of $1.06 billion and an EBITDA of $289 million. The EBITDA ratio measures Masimo Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Masimo Corporation’s operating margin was 8.78% while its return on assets stood at 4.02% with a return of equity of 9.22%.

In Q2, Masimo Corporation’s quarterly earnings growth was a negative -12.1% while revenue growth was a negative 19.5%.

Masimo Corporation’s PE and PEG Ratio

Forward PE
40
Trailing PE
49.5755
PEG
4.7295

Its diluted EPS in the last 12-months stands at $2.12 per share while it has a forward price to earnings multiple of 40 and a PEG multiple of 4.7295. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Masimo Corporation’s profitability.

Masimo Corporation stock is trading at a EV to sales ratio of 4.8333 and a EV to EBITDA ratio of 28.6553. Its price to sales ratio in the trailing 12-months stood at 4.3437.

Masimo Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$3.01 billion
Total Liabilities
$571.90 million
Operating Cash Flow
$-22400000.00
Capital Expenditure
$22.10 million
Dividend Payout Ratio
0%

Masimo Corporation ended 2024 with $3.01 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.01 billion while shareholder equity stood at $1.31 billion.

Masimo Corporation ended 2024 with $0 in deferred long-term liabilities, $571.90 million in other current liabilities, 100000.00 in common stock, $1.75 billion in retained earnings and $410.90 million in goodwill. Its cash balance stood at $150.70 million and cash and short-term investments were $150.70 million. The company’s total short-term debt was $49,500,000 while long-term debt stood at $888.80 million.

Masimo Corporation’s total current assets stands at $1.21 billion while long-term investments were $13.90 million and short-term investments were $0. Its net receivables were $348.80 million compared to accounts payable of $265.50 million and inventory worth $542.60 million.

In 2024, Masimo Corporation's operating cash flow was $-22400000.00 while its capital expenditure stood at $22.10 million.

Comparatively, Masimo Corporation paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$98.47
52-Week High
$198
52-Week Low
$98.04
Analyst Target Price
$148.63

Masimo Corporation stock is currently trading at $98.47 per share. It touched a 52-week high of $198 and a 52-week low of $198. Analysts tracking the stock have a 12-month average target price of $148.63.

Its 50-day moving average was $121.88 and 200-day moving average was $155.46 The short ratio stood at 2.64 indicating a short percent outstanding of 0%.

Around 679% of the company’s stock are held by insiders while 8621.4% are held by institutions.

Frequently Asked Questions About Masimo Corporation

The stock symbol (also called stock or share ticker) of Masimo Corporation is MASI

The IPO of Masimo Corporation took place on 2007-08-08

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$1.46
-0.12
-7.59%
$28.76
0.01
+0.03%
$2.37
-0.05
-2.07%
$48.85
-0.19
-0.39%
SintokogioLtd (SILDF)
$7.48
-0.07
-0.93%
$716.25
-8.6
-1.19%
$9.16
0.09
+0.99%
$371.8
-30.2
-7.51%
$35.04
-0.01
-0.03%
$29.28
-0.13
-0.44%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Address

52 Discovery, Irvine, CA, United States, 92618